Descovy and Fear - a phase IV clinical study of FDA data
Summary:
Fear is reported as a side effect among people who take Descovy (emtricitabine; tenofovir alafenamide fumarate), especially for people who are male, 50-59 old, also take Truvada, and have Hypersensitivity.
The phase IV clinical study analyzes which people have Fear when taking Descovy. It is created by eHealthMe based on reports of 14,206 people who have side effects when taking Descovy from the FDA, and is updated regularly.
What is Descovy?
Descovy has active ingredients of emtricitabine; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 14,260 Descovy users. Check the latest studies of Descovy.
What is Fear?
Fear is found to be associated with 1,424 drugs and 1,583 conditions by eHealthMe. Check the latest studies of Fear.
14,206 people reported to have side effects when taking Descovy.
Among them, 25 people (0.18%) have Fear.

Among these 25 people:
What is the gender of people who have Fear when taking Descovy? *
- female: 32 %
- male: 68 %
What is the age of people who have Fear when taking Descovy? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 15 %
- 40-49: 20 %
- 50-59: 50 %
- 60+: 15 %
What are other drugs people take besides Descovy? *
- Truvada: 22 people, 88.00%
- Tivicay: 14 people, 56.00%
- Norvir: 13 people, 52.00%
- Atripla: 11 people, 44.00%
- Lyrica: 9 people, 36.00%
- Prezista: 8 people, 32.00%
- Isentress: 8 people, 32.00%
- Reyataz: 7 people, 28.00%
- Combivir: 7 people, 28.00%
- Sustiva: 7 people, 28.00%
What are other side effects people have besides Fear? *
- Pain: 24 people, 96.00%
- Stress And Anxiety: 24 people, 96.00%
- Emotional Distress: 24 people, 96.00%
- Anhedonia (inability to experience pleasure from activities usually found enjoyable): 24 people, 96.00%
- Quality Of Life Decreased: 20 people, 80.00%
- Decreased Activity: 14 people, 56.00%
- Chronic Kidney Disease: 13 people, 52.00%
- Osteoporosis (bones weak and more likely to break): 11 people, 44.00%
- Fatigue (feeling of tiredness): 8 people, 32.00%
- Depression: 8 people, 32.00%
What are the existing conditions these people have? *
- Hypersensitivity: 5 people, 20.00%
- Stress And Anxiety: 3 people, 12.00%
- Rickets (softening of bones): 3 people, 12.00%
- Rashes (redness): 3 people, 12.00%
- Pain: 3 people, 12.00%
- Infection: 3 people, 12.00%
- Fungal Infection: 3 people, 12.00%
- Dyspnea (difficult or laboured breathing): 3 people, 12.00%
- Cough: 3 people, 12.00%
- Bacterial Infection: 3 people, 12.00%
* Approximation only. Some reports may have incomplete information.
Do you take Descovy and have Fear?
- Check whether Fear is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Descovy:
- Descovy (14,260 reports)
Fear treatments and more:
- Fear (37,823 reports)
How severe was Fear and when was it recovered:
Expand to all the drugs that have ingredients of emtricitabine; tenofovir alafenamide fumarate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Descovy:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Fear:
- Fear (1,425 drugs)
Browse all the conditions that are associated with Fear:
- Fear (1,583 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on emtricitabine; tenofovir alafenamide fumarate (the active ingredients of Descovy) and Descovy (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ribavirin cause Angiotensin Converting Enzyme Increased? - 6 seconds ago
- Could Pamidronate Disodium cause Klebsiella Infection? - 17 seconds ago
- Drug interactions of Nitrostat and Fiorinal - 20 seconds ago
- Could Spiriva cause Escherichia Bacteraemia? - 36 seconds ago
- Could Nasacort Aq cause Swelling? - 44 seconds ago
- Drug interactions of Letrozole and Chondroitin - 51 seconds ago
- Cough and Tonsillitis - a minute ago
- Drug interactions of Nitroglycerin and Naltrexone - a minute ago
- Oesophagitis and Sleep Disorder - a minute ago
- Could Gentamicin cause Listeriosis? - a minute ago